Clipping of news on Brazilian Culture, Law and Citizenship
21/05/2012
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Cancer incidence was lower in patients taking statins.
Cancer is the leading cause of death in patients with transplanted heart.
The use of drugs shown to lower cholesterol, known as "statins", prevents cancer and improves survival of people who have undergone heart transplantation, according to a survey of the European Society of Cardiology.
Statins are drugs that act on the immune system and are generally used to lower cholesterol considered bad. But to be given to transplant patients, the researchers noticed that cases of cancer and decreased life span increased between them.
According to the study, cancer is the leading cause of death in patients with transplanted heart. In these cases, the onset of skin cancer, bowel, prostate and lymphomas are also common.
The study included all 255 patients who underwent heart transplant at University Hospital Zurich, Switzerland, between 1985 and 2007 and who were alive one year after surgery.
Through these analyzes, the researchers found that statins reduced the risk by 65% of these patients had any cancer. Eight years after transplantation the incidence of tumors was 34% in patients who did not use the medication, while among those who used the rate was 13%. The benefit has proved durable in 10 years: 39% versus 18% among those who use, and 12 years (42% versus 22%).
From this evidence, the study concluded that the increased rate of cancer in those who received a heart transplant may be related to weakened immune system.
Source: G1 News
Our news are taken in full of our partner sites. For this reason, we can not change the content of these up in case of typing errors.
This article was translated by an automatic translation system, and was therefore not reviewed by people.